BioCardia (BCDA) EPS (Basic) Growth (3y) (2019 - 2026)
Powered by 
Analysis
BioCardia (BCDA) EPS (Basic) Growth (3y) (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.60 Bn | 9.76 Bn | 112.79 Mn | 51.67% |
| 2 | CRISPR Therapeutics AG | 5.39 Bn | 5.39 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.98 Bn | 3.68 Bn | 55.72 Mn | 39.50% |
| 4 | Legend Biotech | 3.97 Bn | 3.00 Bn | 251.50 Mn | 32.71% |
| 5 | uniQure | 3.09 Bn | 3.09 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 3.06 Bn | 3.06 Bn | - | - |
| 7 | Precigen | 2.54 Bn | 2.54 Bn | 52.17 Mn | - |
| 8 | Sarepta Therapeutics | 2.38 Bn | 1.58 Bn | 251.87 Mn | 44.39% |
| 9 | Vericel | 2.06 Bn | 1.89 Bn | 56.40 Mn | 34.14% |
| 10 | BioCardia | 13.06 Mn | 8.94 Mn | - | 62.48% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 62.48% |
| Mar 31, 2026 | 56.85% |
| Sep 30, 2025 | 54.83% |
| Jun 30, 2025 | 42.40% |
| Mar 31, 2025 | 41.41% |
| Dec 31, 2024 | 24.51% |
| Sep 30, 2024 | 36.08% |
| Jun 30, 2024 | 34.09% |
| Mar 31, 2024 | 20.38% |
| Dec 31, 2023 | 34.21% |
| Sep 30, 2023 | 26.68% |
| Jun 30, 2023 | 28.50% |
| Mar 31, 2023 | 36.35% |
| Dec 31, 2022 | 35.21% |
| Sep 30, 2022 | 32.34% |
| Jun 30, 2022 | 43.31% |
| Mar 31, 2022 | 36.48% |
| Dec 31, 2021 | 38.00% |
| Sep 30, 2021 | 42.62% |
| Jun 30, 2021 | 35.58% |